Induced pluripotent stem cells for development of cancer immunotherapy - A viable idea for less toxic treatment
Keywords:Cancer management, induced pleuripotent stem cells, monoclonal antibodies
Induced pluripotent stem cells were introduced by Prof. Yamanaka and now being studied in all stem cells related treatment methods. Cancer immunotherapy is now part of targeted therapy and showing promising results, however the cost of treatment and tagged risk of side effects making it difficult for patients. Thus use of induced pluripotent stem cells to grow into plasma cells and produce antibodies against cancer targets will be a breakthrough in cancer management
Copyright (c) 2022 Dr. Binafsha Manzoor Syed
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: Open access journal copyright lies with authors and protected under CC BY-NC-ND 4.0 licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).